CRISPR-Cas9

Using a large-scale siRNA screen and CRISPR-Cas9 technology, researchers have pinpointed genes that can enhance antibody production in Chinese hamster ovary cells.

From replacing the insulin producing cells of the body, to serving as genetic and drug screening platforms, stem cells could change the landscape of available treatments for diabetes.

Leveraging the power of CRISPR-Cas9 to awaken antibiotics from their silent gene clusters

A rapid genome editing
technique that can be switched on and off by a simple chemical cue holds great
promise for stem cell studies